Terms: = Leukemia AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Clinical Outcome
14 results:
1. clinical features and prognostic implications of ecotropic viral integration site 1 (
Jia M; Hu BF; Zhang JY; Xu LY; Tang YM
Pediatr Hematol Oncol; 2023 May; 40(4):371-381. PubMed ID: 36111831
[TBL] [Abstract] [Full Text] [Related]
2.
Elsherif M; Hammad M; Hafez H; Yassin D; Ashraf M; Yasser N; Lehmann L; Elhaddad A
Acta Oncol; 2022 Apr; 61(4):516-522. PubMed ID: 35038958
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of myeloid neoplasms with nonclassic 3q26.2/mecom versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of mecom activation.
Gao J; Gurbuxani S; Zak T; Kocherginsky M; Ji P; Wehbe F; Chen Q; Chen YH; Lu X; Jennings L; Frankfurt O; Altman J; Sukhanova M
Genes Chromosomes Cancer; 2022 Feb; 61(2):71-80. PubMed ID: 34668265
[TBL] [Abstract] [Full Text] [Related]
4. evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation.
Mizuno H; Koya J; Masamoto Y; Kagoya Y; Kurokawa M
Cancer Sci; 2021 Oct; 112(10):4112-4126. PubMed ID: 34363719
[TBL] [Abstract] [Full Text] [Related]
5. evi1 dysregulation: impact on biology and therapy of myeloid malignancies.
Birdwell C; Fiskus W; Kadia TM; DiNardo CD; Mill CP; Bhalla KN
Blood Cancer J; 2021 Mar; 11(3):64. PubMed ID: 33753715
[TBL] [Abstract] [Full Text] [Related]
6. The creatine kinase pathway is a metabolic vulnerability in evi1-positive acute myeloid leukemia.
Fenouille N; Bassil CF; Ben-Sahra I; Benajiba L; Alexe G; Ramos A; Pikman Y; Conway AS; Burgess MR; Li Q; Luciano F; Auberger P; Galinsky I; DeAngelo DJ; Stone RM; Zhang Y; Perkins AS; Shannon K; Hemann MT; Puissant A; Stegmaier K
Nat Med; 2017 Mar; 23(3):301-313. PubMed ID: 28191887
[TBL] [Abstract] [Full Text] [Related]
7. Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid.
Verhagen HJ; Smit MA; Rutten A; Denkers F; Poddighe PJ; Merle PA; Ossenkoppele GJ; Smit L
Blood; 2016 Jan; 127(4):458-63. PubMed ID: 26582376
[TBL] [Abstract] [Full Text] [Related]
8. 3q26/evi1 rearrangements in myeloid hemopathies: a cytogenetic review.
De Braekeleer M; Le Bris MJ; De Braekeleer E; Basinko A; Morel F; Douet-Guilbert N
Future Oncol; 2015; 11(11):1675-86. PubMed ID: 26043219
[TBL] [Abstract] [Full Text] [Related]
9. The regulatory interaction of evi1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract] [Full Text] [Related]
10. clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
Renneville A; Abdelali RB; Chevret S; Nibourel O; Cheok M; Pautas C; Duléry R; Boyer T; Cayuela JM; Hayette S; Raffoux E; Farhat H; Boissel N; Terre C; Dombret H; Castaigne S; Preudhomme C
Oncotarget; 2014 Feb; 5(4):916-32. PubMed ID: 24659740
[TBL] [Abstract] [Full Text] [Related]
11. Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients.
Bou Samra E; Klein B; Commes T; Moreaux J
Oncotarget; 2012 Aug; 3(8):824-32. PubMed ID: 22910040
[TBL] [Abstract] [Full Text] [Related]
12. High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.
Noordermeer SM; Sanders MA; Gilissen C; Tönnissen E; van der Heijden A; Döhner K; Bullinger L; Jansen JH; Valk PJ; van der Reijden BA
Blood; 2011 Nov; 118(20):5613-21. PubMed ID: 21937695
[TBL] [Abstract] [Full Text] [Related]
13. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia.
Trubia M; Albano F; Cavazzini F; Cambrin GR; Quarta G; Fabbiano F; Ciambelli F; Magro D; Hernandezo JM; Mancini M; Diverio D; Pelicci PG; Coco FL; Mecucci C; Specchia G; Rocchi M; Liso V; Castoldi G; Cuneo A
Leukemia; 2006 Jan; 20(1):48-54. PubMed ID: 16619048
[TBL] [Abstract] [Full Text] [Related]